BCL2 and acute lymphoblastic leukemia: Furthermore, the modulation of apoptosis in patients with ALL relapse is aberrantly inactive, as demonstrated by a reduced Bax/Bcl-2 ratio and a decrease in spontaneous caspase-3 processing [20].